Compare ZNTL & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZNTL | OIA |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.7M | 293.7M |
| IPO Year | 2020 | 1994 |
| Metric | ZNTL | OIA |
|---|---|---|
| Price | $2.56 | $5.97 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 627.3K | 85.3K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.87 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,425,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $5.43 |
| 52 Week High | $3.95 | $6.40 |
| Indicator | ZNTL | OIA |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 26.06 |
| Support Level | $1.29 | $5.93 |
| Resistance Level | $2.69 | $6.11 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 37.92 | 7.32 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.